ZAGREB, 2 Nov (Hina) - The Zora Foundation is trying to raise a million euros to start the Croatian production of preparations for Chimeric Antigen Receptor T-cell (CAR T-cell) immunotherapy, which achieves better outcomes in the treatment of leukaemia and lymphoma than all other available therapies.
(Hina) vm